Skip to main content
. 2016 Jul 24;82(4):1058–1068. doi: 10.1111/bcp.13034

Figure 3.

Figure 3

Reported drugs by anatomical main group and role (suspect/interacting or concomitant) in the occurrence of adverse reactions (A) alimentary tract and metabolism, (B) blood and blood forming organs, (C) cardiovascular system, (D) dermatologicals, (G) genito‐urinary system and sex hormones, (H) systemic hormonal preparations, excluding sex hormones and insulins, (J) anti‐infectives for systemic use, (L)antineoplastic and immunomodulating agents, (M) musculo‐skeletal system, (N) nervous system, (P) antiparasitic products, insecticides and repellents, (R) respiratory system, (S) sensory organs, (V) various, (U) unknown (ATC code could not be attributed because the commercial name or active substance of the drug were missing) and (NA) not applicable (no ATC codes attributed to these substances). Inline graphic suspect/interacting drugs, Inline graphic concomittant drugs